General Catalyst Group Management, LLC
General Catalyst Group Management, LLC reported 14 holdings worth US$189M as of Jun 30, 2026 (Form 13F)
As of Jun 30, 2026 · Filed Aug 17, 2026
General Catalyst Group Management, LLC reported 14 holdings worth US$189M as of Jun 30, 2026. Largest: Arrivent Biopharma, Inc., Parabilis Medicines, Inc. and Maplebear Inc. Filed Aug 17, 2026 (Form 13F).
- Holdings
- 14
- Value as reported
- US$189M
The filing in full
| Company | Shares | Value as reported | % of portfolio |
|---|---|---|---|
| Arrivent Biopharma, Inc. | 1.49M | US$51.9M | 27.5% |
| Parabilis Medicines, Inc. | 1.6M | US$43.8M | 23.2% |
| Maplebear Inc. | 711K | US$33.7M | 17.9% |
| Maze Therapeutics, Inc. | 1.04M | US$30.9M | 16.4% |
| Odyssey Therapeutics, Inc. | 810K | US$15.2M | 8.0% |
| Eikon Therapeutics, Inc. | 305K | US$3.98M | 2.1% |
| Fractyl Health, Inc. | 4.88M | US$3.88M | 2.1% |
| Ethos Technologies Inc. | 74,179 | US$1.35M | 0.71% |
| Coupang, Inc. | 54,677 | US$950K | 0.50% |
| Amazon.com, Inc. | 3,882 | US$925K | 0.49% |
| Meta Platforms, Inc. | 1,320 | US$744K | 0.39% |
| Doordash, Inc. | 2,850 | US$526K | 0.28% |
| Carvana Co. | 6,465 | US$426K | 0.23% |
| Figma Inc | 14,845 | US$269K | 0.14% |
| Gitlab Inc. | 0 | US$0 | 0.00% |
| Samsara Inc. | 0 | US$0 | 0.00% |